Last reviewed · How we verify

NCT06762795

The HIEnome Study: Genome Sequencing for Perinatal HIE

Recruiting now NA Last updated 1 October 2025
What this trial tests

NA trial testing Genome sequencing in Hypoxic Ischemic Encephalopathy of Newborn in 25 participants. Currently enrolling.

Timeline
15 May 2025
Primary endpoint
31 March 2027
30 June 2027

Quick facts

Lead sponsorBaylor College of Medicine
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment25
Start date15 May 2025
Primary completion31 March 2027
Estimated completion30 June 2027
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Baylor College of Medicine

Who can join

Adults 0 Days to 1, any sex, with Hypoxic Ischemic Encephalopathy of Newborn or Hypoxic Ischemic Encephalopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Perinatal hypoxic-ischemic encephalopathy is a rare severe condition in which neonates present with encephalopathy and a clinical history suggestive of prenatal or perinatal hypoxic-ischemic injury. Emerging evidence suggests that genetic conditions are frequently identified in cases of perinatal HIE; however, it is unclear which neonates with this diagnosis warrant genetic testing. This study will offer clinical genome sequencing to neonates with HIE who are undergoing total body cooling (therapeutic hypothermia) and their parents.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Genome sequencing

Trials testing the same drug.

Other recruiting trials for Hypoxic Ischemic Encephalopathy of Newborn

Currently open trials in the same condition.

Other Baylor College of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06762795.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing